These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8877270)

  • 1. Dyslipidemia in diabetes mellitus.
    Yoshino G; Hirano T; Kazumi T
    Diabetes Res Clin Pract; 1996 Jun; 33(1):1-14. PubMed ID: 8877270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
    Laakso M; Pyörälä K
    Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.
    Stewart MW; Laker MF; Dyer RG; Game F; Mitcheson J; Winocour PH; Alberti KG
    Arterioscler Thromb; 1993 Jul; 13(7):1046-52. PubMed ID: 8318506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic lipoproteins and diabetes mellitus.
    Yoshino G; Hirano T; Kazumi T
    J Diabetes Complications; 2002; 16(1):29-34. PubMed ID: 11872363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
    Kissebah AH; Alfarsi S; Evans DJ; Adams PW
    Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyperlipidemia in diabetes mellitus].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():143-51. PubMed ID: 11347047
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
    Ginsberg HN
    Diabetes Care; 1991 Sep; 14(9):839-55. PubMed ID: 1959476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
    Hirano T; Naito H; Kurokawa M; Ebara T; Nagano S; Adachi M; Yoshino G
    Atherosclerosis; 1996 Jun; 123(1-2):57-72. PubMed ID: 8782837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
    Tan KC; Cooper MB; Ling KL; Griffin BA; Freeman DJ; Packard CJ; Shepherd J; Hales CN; Betteridge DJ
    Atherosclerosis; 1995 Mar; 113(2):273-87. PubMed ID: 7605366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.
    Schernthaner G; Kostner GM; Dieplinger H; Prager R; Mühlhauser I
    Atherosclerosis; 1983 Dec; 49(3):277-93. PubMed ID: 6229255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects.
    Bioletto S; Golay A; Munger R; Kalix B; James RW
    Am J Clin Nutr; 2000 Feb; 71(2):443-9. PubMed ID: 10648256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic hypertriglyceridemia: evidence for three clinical syndromes.
    Reaven GM; Greenfield MS
    Diabetes; 1981; 30(Suppl 2):66-75. PubMed ID: 7028540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia.
    Greenfield M; Kolterman O; Olefsky J; Reaven GM
    Diabetologia; 1980 Jun; 18(6):441-6. PubMed ID: 7418956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications.
    Steiner G
    Am J Cardiol; 1986 May; 57(14):27G-30G. PubMed ID: 3521248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.